Organovo Holdings, Inc. (0R02.L)

USD 0.38

(-3.43%)

Revenue Summary of Organovo Holdings, Inc.

  • Organovo Holdings, Inc.'s latest annual revenue in 2023 was 109 Thousand USD , down -70.54% from previous year.
  • Organovo Holdings, Inc.'s latest quarterly revenue in 2024 Q1 was 39 Thousand USD , up 34.48% from previous quarter.
  • Organovo Holdings, Inc. reported a annual revenue of 370 Thousand USD in annual revenue 2022, down -75.33% from previous year.
  • Organovo Holdings, Inc. reported a annual revenue of 1.5 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Organovo Holdings, Inc. reported a quarterly revenue of 5000.00 USD for 2023 Q3, down 0.0% from previous quarter.
  • Organovo Holdings, Inc. reported a quarterly revenue of 75 Thousand USD for 2023 Q1, down -53.7% from previous quarter.

Annual Revenue Chart of Organovo Holdings, Inc. (2023 - 2010)

Historical Annual Revenue of Organovo Holdings, Inc. (2023 - 2010)

Year Revenue Revenue Growth
2023 109 Thousand USD -70.54%
2022 370 Thousand USD -75.33%
2021 1.5 Million USD 0.0%
2020 - USD -100.0%
2019 2.19 Million USD -28.96%
2018 3.09 Million USD -32.85%
2017 4.6 Million USD 8.82%
2016 4.23 Million USD 185.23%
2015 1.48 Million USD 159.72%
2014 571 Thousand USD 50.66%
2013 379 Thousand USD -68.34%
2012 1.19 Million USD 0.0%
2010 - USD 0.0%

Peer Revenue Comparison of Organovo Holdings, Inc.

Name Revenue Revenue Difference
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.934%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.955%
Codexis, Inc. 70.14 Million USD 99.845%
Viridian Therapeutics, Inc. 314 Thousand USD 65.287%